Request Demo
Last update 01 Feb 2026
Beijing Gene Key Life Technology Co., Ltd
Subsidiary Company|2015|Beijing Shi, China|
10-50
Subsidiary Company|2015|Beijing Shi, China|
10-50
Last update 01 Feb 2026
Overview
Tags
Digestive System Disorders
Neoplasms
Endocrinology and Metabolic Disease
iNKT cell therapy
CAR-NKT
Natural killer T cell
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20253777
GKL-006注射液联合经动脉化疗栓塞（TACE）对比单纯TACE治疗不可切除的肝细胞癌的多中心、随机、开放、对照的II期临床试验
[Translation] A multicenter, randomized, open-label, controlled phase II clinical trial of GKL-006 injection combined with transarterial chemoembolization (TACE) versus TACE alone in the treatment of unresectable hepatocellular carcinoma
NCT07209813
A Phase Ⅱ, Multicenter, Parallel Comparison Clinical Study of GKL-006 Combined With TACE in Treatment of Unresectable Hepatocellular Carcinoma
CTR20252552
评价GKL-006注射液治疗晚期胰腺癌患者的安全性、耐受性、药代动力学特征和初步疗效的Ⅰ/Ⅱa期临床试验
[Translation] Phase I/IIa clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of GKL-006 injection in the treatment of patients with advanced pancreatic cancer
100 Clinical Results associated with Beijing Gene Key Life Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Beijing Gene Key Life Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Beijing Gene Key Life Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 30 Mar 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
2
2
Phase 2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free